Net Worth Advisory Group Makes New Investment in Astera Labs, Inc. $ALAB

Net Worth Advisory Group bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 2,896 shares of the company’s stock, valued at approximately $1,032,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Greenleaf Trust raised its position in Astera Labs by 1.8% in the second quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock valued at $966,000 after purchasing an additional 36 shares during the period. Parkside Financial Bank & Trust lifted its stake in shares of Astera Labs by 74.5% during the second quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock worth $46,000 after purchasing an additional 41 shares in the last quarter. Glenmede Trust Co. NA boosted its position in shares of Astera Labs by 2.7% in the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after buying an additional 51 shares during the period. Keating Financial Advisory Services Inc. purchased a new stake in shares of Astera Labs in the second quarter worth about $25,000. Finally, Integrated Wealth Concepts LLC boosted its position in shares of Astera Labs by 0.7% in the second quarter. Integrated Wealth Concepts LLC now owns 7,006 shares of the company’s stock worth $3,384,000 after buying an additional 52 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on ALAB shares. Royal Bank Of Canada raised their target price on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. UBS Group reissued a “neutral” rating and set a $425.00 price target on shares of Astera Labs in a research report on Wednesday, August 5th. Morgan Stanley upped their price target on Astera Labs to $335.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. Roth Capital restated a “buy” rating and issued a $450.00 price target on shares of Astera Labs in a report on Wednesday, August 5th. Finally, Citigroup downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a research report on Friday, October 9th. Eleven analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat, Astera Labs presently has an average rating of “Moderate Buy” and an average price target of $348.33.

Astera Labs Stock Performance

Shares of ALAB stock opened at $286.58 on Tuesday. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48. The company’s 50-day simple moving average is $314.24 and its 200-day simple moving average is $299.64. The stock has a market capitalization of $49.72 billion, a price-to-earnings ratio of 184.40 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same period in the previous year, the company earned $0.44 earnings per share. Astera Labs’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, research analysts forecast that Astera Labs, Inc. will post 2.70 EPS for the current year.

Insider Activity at Astera Labs

In other news, CEO Jitendra Mohan sold 90,630 shares of Astera Labs stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief executive officer owned 1,266,665 shares in the company, valued at approximately $431,109,432.75. This trade represents a 6.68% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief operating officer owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. This trade represents a 7.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 408,558 shares of company stock worth $127,306,034 over the last quarter. 10.40% of the stock is owned by corporate insiders.

Astera Labs Company Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.